HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Grygier Selected Research

AZ 12216052

9/2015Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Grygier Research Topics

Disease

2Neuroblastoma
09/2015 - 08/2014
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022
1Parkinson Disease (Parkinson's Disease)
08/2014

Drug/Important Bio-Agent (IBA)

1Imiquimod (Aldara)FDA LinkGeneric
08/2022
1Secretory Leukocyte Peptidase InhibitorIBA
08/2022
1metabotropic glutamate receptor 8IBA
09/2015
1N,N'-dibenzhydrylethane-1,2-diamine dihydrochlorideIBA
09/2015
1AZ 12216052IBA
09/2015
1N- (4- chloro- 3- methoxyphenyl)- 2- picolinamideIBA
09/2015
1metabotropic glutamate receptor 7IBA
09/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2015
1eglumetadIBA
09/2015
11-aminocyclopentane-1,3,4-tricarboxylic acidIBA
09/2015
1metabotropic glutamate receptor 4IBA
09/2015
1Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2015
1StaurosporineIBA
09/2015
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
08/2014
1Neuroprotective AgentsIBA
08/2014
1NeurotoxinsIBA
08/2014